Genzyme’s Commitment to Patients

“From the beginning, our efforts have been directed toward improving the lives of patients. This has meant much more than simply developing and selling a drug. It has meant establishing comprehensive programs and services dedicated to helping patients with chronic, debilitating diseases and their families. We have expanded this commitment to meet the needs of patients with inherited disorders worldwide. Our commitment to meet the needs of our patients permeates every endeavor underway at Genzyme.”

— Henri Termeer, President and CEO of Genzyme Corporation